CCC Intelligent Solutions (CCC) Q4 2025 earnings review
Strong Q4 Finish, But FY26 Guidance Signals Deceleration
CCC exited FY25 with a bang, accelerating revenue growth to 13% in Q4 and officially crossing the $1B annual revenue mark. AI is no longer just a narrative—it is a tangible driver, now contributing roughly $100M (10% of revenue) as customers scale from pilots to production. However, the celebration is tempered by a sobering FY26 guidance: management projects revenue growth to decelerate to ~9%. While profitability remains incredibly stable (43% Q4 adjusted EBITDA margin) and free cash flow easily funds operations, the company is leaning heavily on debt to finance aggressive share buybacks and M&A. Investors must weigh the successful EvolutionIQ integration and rapid AI adoption against a slowing organic top-line trajectory.
🐂 Bull Case
AI solutions now generate ~10% of total revenue (~$100M), scaling across 125 insurers and 15,000+ repair facilities. The transition from testing to widespread deployment is driving measurable top-line impact.
The EvolutionIQ acquisition is succeeding, adding two top-15 disability insurers to reach 9 of the top 15. A new partnership with the world's largest TPA opens up massive whitespace in the self-insured employer market.
🐻 Bear Case
Despite exiting Q4 with 13% growth, FY26 midpoint guidance implies a deceleration to ~9% revenue growth, indicating that Q4 momentum was likely a peak subsidized by M&A rather than a new organic baseline.
FY25 GAAP Net Income plummeted to just $1.7M (from $31.2M) due to massive amortization and stock-based compensation. Meanwhile, total debt surged to $1.29B to fund a new $500M buyback authorization.
⚖️ Verdict: ⚪
Neutral. CCC is a fundamentally sound, highly cash-generative business successfully transitioning its base to AI workflows. However, the guide down to single-digit top-line growth in FY26 makes the stock highly sensitive to valuation multiples, especially as debt levels rise.
Key Themes
AI Crosses the $100M Threshold
AI adoption has evolved from a pilot program narrative into a core revenue engine. It now generates 10% of CCC's total revenue, utilized by 125 insurers and over 15,000 repair facilities. Because claim volume processed via AI models currently ranges from only low single-digits to low double-digits, the runway for deeper penetration and upsell within the existing customer base remains massive.
EvolutionIQ Diversifies the Core
The EvolutionIQ acquisition is executing exactly as promised, diversifying CCC away from its strict reliance on the auto physical damage (APD) cycle. The platform added two top-15 disability insurers in 2025 and now commands 9 of the top 15. More importantly, it established a partnership with the world's largest third-party administrator (TPA), opening a new sales channel.
Aggressive Capital Returns Drive Up Leverage
Management is playing financial engineering to support EPS. After exhausting a $300M program, the Board authorized a new $500M buyback, immediately executing a $300M Accelerated Share Repurchase (ASR). Consequently, Total Debt spiked to $1.29B at year-end (up from $761M in 2024), shifting the balance sheet from conservative to moderately levered.
Macro Headwind: Claims Volume Suppression
A structural macro issue remains a silent drag on growth: record-high insurance premiums are deterring consumers from filing smaller APD claims. This dynamic acted as a ~1% drag on revenue growth throughout FY25. If this shift in consumer behavior is permanent, CCC will be forced to rely entirely on AI cross-selling and price increases to manufacture growth.
GAAP Profitability Crushed by Amortization and SBC
Adjusted EBITDA ($436M) paints a picture of a cash-printing machine, but GAAP Net Income tells a different story: a collapse to $1.7M in FY25 from $31.2M in FY24. The massive gap is bridged by $175.4M in stock-based compensation and a surge in amortization of acquired technologies ($17.5M) and intangibles ($74.0M). The cost of CCC's M&A-driven innovation is heavily burdening the true bottom line.
Other KPIs
Up 10% from FY24 ($230.9M). A healthy ~24% FCF margin demonstrates the underlying cash-generation power of the subscription model. However, operating cash flow alone was insufficient to cover the combined cost of the $600M in stock repurchases and the $410M EvolutionIQ acquisition, necessitating the debt increase.
Decelerating. Full-year adjusted gross margin compressed to 76% from 78% in FY24. Management previously attributed this to higher depreciation from newly launched solutions and the margin mix profile of EvolutionIQ. This compression indicates that the upfront costs of AI innovation are temporarily outstripping pricing power.
Guidance
Decelerating. The midpoint ($1.152B) implies 9.0% YoY growth, a notable step down from the 12% growth achieved in FY25. This confirms that the Q4 acceleration (13%) was likely subsidized by the inorganic addition of EvolutionIQ. With the acquisition now lapping its first year, the core business is reverting to high-single-digit territory.
Stable. The midpoint ($481.0M) implies a 41.7% margin, a slight improvement over FY25's 41.2%. This shows management is committed to operational discipline and extracting leverage from the platform, successfully protecting the bottom line even as top-line growth cools.
Decelerating. The midpoint of $274.5M implies ~9.1% YoY growth, a sharp drop from Q4's 13% rate, and represents a sequential quarter-over-quarter decline. Breaking the double-digit growth streak sets a cautious tone for the start of the fiscal year.
Key Questions
AI Cannibalization vs. Accretion
With AI solutions now handling double-digit percentages of claims for some clients, are these higher-priced AI modules completely accretive, or are they beginning to cannibalize your legacy transaction and processing fees?
Leverage Ceilings and Capital Allocation
Total debt has surged past $1.2B to fund the ASR and acquisitions. What is the board's ceiling for net leverage, and will the primary use of free cash flow in FY26 shift toward deleveraging rather than further buybacks?
Organic vs. Inorganic Growth Baseline
FY25 growth was heavily supported by the EvolutionIQ acquisition. What is the pure organic growth rate assumed in the FY26 midpoint guidance of 9%, and does this assume any recovery in macro claims volumes?